{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:42:13Z","timestamp":1790682133195,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T00:00:00Z","timestamp":1449100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144015","type":"journal-article","created":{"date-parts":[[2015,12,3]],"date-time":"2015-12-03T18:47:51Z","timestamp":1449168471000},"page":"e0144015","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia"],"prefix":"10.1371","volume":"10","author":[{"given":"Wen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2741\/2354","article-title":"TRAIL: a multifunctional cytokine","volume":"12","author":"U Schaefer","year":"2007","journal-title":"Front Biosci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2009.04905.x","article-title":"TRAIL-induced apoptosis: between tumor therapy and immunopathology","volume":"1171","author":"N Corazza","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1096\/fj.08-111005","article-title":"Life and death by death receptors","volume":"23","author":"ME Guicciardi","year":"2009","journal-title":"FASEB J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2174\/138945012802002357","article-title":"TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases","volume":"13","author":"S Bernardi","year":"2012","journal-title":"Curr Drug Targets"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tem.2013.07.001","article-title":"On the TRAIL of obesity and diabetes","volume":"24","author":"HH Harith","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10238-012-0226-1","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what&apos;s new?","volume":"14","author":"A Neve","year":"2014","journal-title":"Clin Exp Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T","article-title":"Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage","volume":"28","author":"SM Mariani","year":"1998","journal-title":"Eur J Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-08-2806","article-title":"IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL\/Apo-2 ligand) displaying apoptotic activity on leukemic cells","volume":"103","author":"C Tecchio","year":"2004","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e4442","DOI":"10.1371\/journal.pone.0004442","article-title":"Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction","volume":"4","author":"P Secchiero","year":"2009","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/ndt\/gfq042","article-title":"The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients","volume":"25","author":"S Liabeuf","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10067-012-2023-3","article-title":"Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement","volume":"31","author":"NA Azab","year":"2012","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/heartjnl-2011-300339","article-title":"Association of soluble tumour necrosis factor-related apoptosis-inducing ligand levels with coronary plaque burden and composition","volume":"98","author":"S Deftereos","year":"2012","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00125-011-2308-0","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe (-)\/(-) mice","volume":"54","author":"BA Di Bartolo","year":"2011","journal-title":"Diabetologia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.2337\/diabetes.52.9.2274","article-title":"Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes","volume":"52","author":"SE Lamhamedi-Cherradi","year":"2003","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1210\/en.2009-0478","article-title":"Systemic delivery of TNF-related apoptosis-inducing ligand (TRAIL) elevates levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prevents type 1 diabetes in nonobese diabetic mice","volume":"151","author":"S Kang","year":"2010","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00592-013-0507-5","article-title":"The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement","volume":"51","author":"G Tornese","year":"2014","journal-title":"Acta Diabetol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/j.diabres.2012.02.028","article-title":"Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients","volume":"96","author":"A Bisgin","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/dmrr.1109","article-title":"Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes","volume":"26","author":"EP O'Sullivan","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"ref19","first-page":"400","article-title":"Associations of serum TRAIL concentrations, anthropometric variables, and serum lipid parameters in healthy adults","volume":"34","author":"JW Choi","year":"2004","journal-title":"Ann Clin Lab Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e58225","DOI":"10.1371\/journal.pone.0058225","article-title":"Association of soluble Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) with central adiposity and low-density lipoprotein cholesterol","volume":"8","author":"G Brombo","year":"2013","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.metabol.2010.10.001","article-title":"Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects","volume":"60","author":"DT Ashley","year":"2011","journal-title":"Metabolism"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e87059","DOI":"10.1371\/journal.pone.0087059","article-title":"TRAIL\/DR5 Signaling Promotes Macrophage Foam Cell Formation by Modulating Scavenger Receptor Expression","volume":"9","author":"FF Liu","year":"2014","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.atherosclerosis.2014.01.022","article-title":"Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment","volume":"233","author":"KB Holven","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/rheumatology\/keq064","article-title":"The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker?","volume":"49","author":"G Castellino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3109\/14767058.2013.783811","article-title":"Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection","volume":"26","author":"P Chaemsaithong","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00277-005-1077-6","article-title":"Relationships between tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and hematopoietic activity in healthy adults","volume":"84","author":"JW Choi","year":"2005","journal-title":"Ann Hematol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2005.08.004","article-title":"Associations of Fas (CD95), tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), and biochemical manifestations in elderly persons","volume":"365","author":"JW Choi","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2362.2012.02703.x","article-title":"The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients","volume":"42","author":"C Davenport","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10072-009-0047-5","article-title":"TNF-related apoptosis-inducing ligand level in Alzheimer&apos;s disease","volume":"30","author":"S Genc","year":"2009","journal-title":"Neurol Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/kel108","article-title":"Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis","volume":"45","author":"LC Hofbauer","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.shk.0000132486.82177.ec","article-title":"Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway","volume":"22","author":"MN Lub-de Hooge","year":"2004","journal-title":"Shock"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/ard.2004.029058","article-title":"Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus","volume":"64","author":"MN Lub-de Hooge","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jacc.2004.12.065","article-title":"The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis","volume":"45","author":"Y Michowitz","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/02841860500482225","article-title":"Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors","volume":"45","author":"PJ Perik","year":"2006","journal-title":"Acta Oncol"},{"key":"ref35","first-page":"PI11","article-title":"Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment","volume":"18","author":"AD Yalcin","year":"2012","journal-title":"Med Sci Monit"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00251-009-0389-4","article-title":"sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease","volume":"61","author":"X Yan","year":"2009","journal-title":"Immunogenetics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.thromres.2009.11.024","article-title":"Association of serum TRAIL level with coronary artery disease","volume":"125","author":"K Mori","year":"2010","journal-title":"Thromb Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vph.2014.10.004","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: a protector or culprit?","volume":"63","author":"W Cheng","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.diabres.2010.11.034","article-title":"Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus","volume":"91","author":"N Kawano","year":"2011","journal-title":"Diabetes Res Clin Pract"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T12:45:13Z","timestamp":1540039513000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144015"}},"subtitle":[],"editor":[{"given":"Ryuichi","family":"Morishita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,3]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144015","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,3]]}}}